abstract |
TETRAHYDROQUINOLINE DERIVATIVES REPLACED WITH 4-CYCLALKYL AND ITS USE AS A MEDICINAL PRODUCT. The present invention relates to a novel tetrahydro-quinoline derivative, a process for its preparation, its use alone or in combinations for the treatment and / or prevention of diseases, as well as its use for the preparation of medicaments particularly as cholesterol ester transfer protein (CETP) inhibitor for the treatment and / or prevention of cardiovascular disease, particularly hypolipoproteinemia, dyslipidemia, hypertriglyceridemia, hyperlipidemia, hypercholesterolemia and arteriosclerosis. |